Trials / Completed
CompletedNCT05206864
Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Solarea Bio, Inc · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical Food: SBD111 | One capsule administered twice daily with morning and evening meals for 28 days |
| OTHER | Placebo | One capsule administered twice daily with morning and evening meals for 28 days |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-01-05
- Completion
- 2022-02-05
- First posted
- 2022-01-25
- Last updated
- 2022-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05206864. Inclusion in this directory is not an endorsement.